Keywords
VEGF
ET-1
eNOS
leptin
adiponectin
How to Cite
Abstract
Pregnancy in obese women is often complicated by hypertensive disorders, Gestational Diabetes Mellitus (GDM), diabetic fetopathy. The aim of the study was to investigate endothelial and hormonal parameters in the blood of pregnant women with gestational diabetes mellitus in the setting of obesity and their influence on the occurrence of perinatal complications. The 54 pregnant women included in the study were divided into four groups: obese pregnant women without GDM (n=12), non-obese pregnant women with GDM (n=16), and obese pregnant women with GDM (n=15), who were compared with healthy non-obese pregnant women (n=11). Indicators of endothelial dysfunction, obesity hormones, cytokines, namely Vascular Endothelial Growth Factor (VEGF), EndoThelin-1 (ET-1), eNOS, leptin, adiponectin, IL-1ß, IL-10 were studied. There were changes in endothelial parameters in pregnant women with GDM against the background of obesity and GDM alone, which significantly differed from the group of obese pregnant women and control subjects (р<0.001), indicating the possibility of developing endothelial dysfunction in pregnant women under the influence of GDM. The levels of leptin, adiponectin and IL-10 significantly increased in obese pregnant women with GDM, while IL-1ß significantly differed from the control values only in obese pregnant women. Therefore, these hormones and cytokines may influence the occurrence of GDM in obese women and should be taken into account when planning pregnancy and childbirth. The harmful effects associated with GDM may be exacerbated by maternal supraphysiological weight gain during pregnancy. That is why determination of VEGF, ET-1, eNOS, leptin, adiponectin, IL-1ß and IL-10 levels in obese women with gestational diabetes is extremely important for choosing an adequate algorithm for pregnancy management and for identifying perinatal lesions, and, if necessary, inducing labour to improve maternal and perinatal outcomes.
Keywords: pregnancy, VEGF, ET-1, eNOS, leptin, adiponectin.
References
Creanga AA, Catalano PM, Bateman BT. Obesity in Pregnancy. N Engl J Med. 2022;387(3):248-59. DOI: 10.1056/NEJMra1801040. PMID: 35857661.
Dluski DF, Ruszala M, Rudzinski G, Pozarowska K, Brzuszkiewicz K, Leszczynska-Gorzelak B. Evolution of Gestational Diabetes Mellitus across Continents in 21st Century. Int J Environ Res Public Health. 2022;19(23):15804. DOI: 10.3390/ijerph192315804. PMID: 36497880.
Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946. DOI: 10.1136/bmj-2021-067946. PMID: 35613728.
Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022;43(5):763-93. DOI: 10.1210/endrev/bnac003. PMID: 35041752.
Musa E, Salazar-Petres E, Arowolo A, Levitt N, Matjila M, Sferruzzi-Perri AN. Obesity and gestational diabetes independently and collectively induce specific effects on placental structure, inflammation and endocrine function in a cohort of South African women. J Physiol. 2023;601(7):1287-306. DOI: 10.1113/JP284139. PMID: 36849131.
Watson Ray G, Zeng Q, Kusi P, Zhang H, Shao T, Yang T, et al. Genetic and inflammatory factors underlying gestational diabetes mellitus: a review. Front Endocrinol (Lausanne). 2024;15:1399694. DOI: 10.3389/fendo.2024.1399694. PMID: 38694942.
Lakhno I. The Insight into Obstetric Care near the Front Line in Kharkiv. Acta Medica Lituanica. 2022;29(2):187-95. DOI: 10.15388/Amed.2022.29.2.10.
Avramenko T, Makarenko M, Govsieiev D. Regulatory effect of endothelial dysfunction and microcirculation pathology in pregnant women diagnosed with diabetes mellitus. J Glob Pharm Technol. 2017;11(9):48-52.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl_1):S13-27. DOI: 10.2337/dc18-S002. PMID: 29222373.
Tsakiridis I, Giouleka S, Mamopoulos A, Kourtis A, Athanasiadis A, Filopoulou D, et al. Diagnosis and Management of Gestational Diabetes Mellitus: An Overview of National and International Guidelines. Obstet Gynecol Surv. 2021;76(6):367-81. DOI: 10.1097/OGX.0000000000000899. PMID: 34192341.
Song X, Wang C, Wang T, Zhang S, Qin J. Obesity and risk of gestational diabetes mellitus: A two-sample Mendelian randomization study. Diabetes Res Clin Pract. 2023;197:110561. DOI: 10.1016/j.diabres.2023.110561. PMID: 36738839.
Janbakhishov T, Caglayan E, Acet F, Altunyurt S, Ozer E. Effect of vascular endothelial growth factor on fetal vessels among obese pregnant women. Int J Gynaecol Obstet. 2020;151(2):231-6. DOI: 10.1002/ijgo.13346. PMID: 32790905.
Gupta AK, Ravussin E, Johannsen DL, Stull AJ, Cefalu WT, Johnson WD. Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes. Br J Med Med Res. 2012;2(3):413-23. DOI: 10.9734/bjmmr/2012/1479. PMID: 22905340.
Salvolini E, Vignini A, Sabbatinelli J, Lucarini G, Pompei V, Sartini D. et al. Nitric oxide synthase and VEGF expression in full-term placentas of obese women. Histochem Cell Biol. 2019;152(6):415-22. DOI: 10.1007/s00418-019-01819-y. PMID: 31552486.
Dubova EA, Pavlov KA, Borovkova EI, Bayramova MA, Makarov IO, Shchegolev AI. Vascular endothelial growth factor and its receptors in the placenta of pregnant women with obesity. Bull Exp Biol Med. 2011;151(2):253-8. DOI: 10.1007/s10517-011-1302-3. PMID: 22238763.
Estemberg D, Kowalska-Koprek U, Brzozowska M, Kus E, Berner-Trabska M, Karowicz-Bilinska A. The assessment of leptin concentration and Vascular Endothelial Growth Factor (VEGF) in relation to the body mass index since 20th week of pregnancy. Ginekol Pol. 2009;80(5):338-42. PMID: 19548452.
Sarunic AV, Cvijanovic O, Dudaric L, Denona B, Vukelic L, Bobinac D, et al. The influence of clinical and anthropometric parameters on the serum levels of the endothelin-1 in pregnant women and their newborns. Coll Antropol. 2012;36(2):395-400. PMID: 22856221.
Shaheen G, Jahan S, Bibi N, Ullah A, Faryal R, Almajwal A, et al. Association of endothelial nitric oxide synthase gene variants with preeclampsia. Reprod Health. 202;18(1):163. DOI: 10.1186/s12978-021-01213-9. PMID: 34321043.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.